| Literature DB >> 33482695 |
Paul Zarogoulidis1, Haidong Huang2, Jun Zhou3, Yunye Ning2, Meng Yang2,4, Jiannan Wang2, Rong Zhang2, Chong Bai2, Xiaping Shen5, Zhiang Huang6, Dimitris Petridis7, Christoforos Kosmidis1, Maria Kosmidou8, Kosmas Tsakiridis9, Wolfgang Hohenforst-Schmidt10, Sofia Baka11, Savas Petanidis12, Bojan Zaric13, Tomi Kovacevic13, Vladimir Stojsic13, Tatjana Sarcev13, Daliborka Bursac13, Biljana Kukic14, Aggeliki Rapti15, Stelian Pantea1,6, Otelia Rogoveanu16, Ion Rogoveanu16, Konstantinos Romanidis17, Issak Kesisoglou1, Aris Ioannidis18, Anastasios Vagionas19, Konstantinos Sapalidis1.
Abstract
INTRODUCTION: Thyroid cancer is usually diagnosed both with imaging techniques and transdermal biopsy. Laboratory tests are also included in the initial work-up. PATIENTS AND METHODS: One hundred and thirty patients were included in our study with pathological imaging findings in the thyroid region. Biopsies were performed with 22 G with transdermal convex probe, EBUS 22 G Mediglobe® needle and 19 G Olympus® needle. We investigated the efficiency and safety of both techniques and identified the best candidates for each method. DISCUSSION: 19 G needle identified cancer types such as; Lymphoma, Medullary thyroid cancer, and Hurthle cell cancer, which we know from previous pathology studies that a larger sample is necessary for diagnosis. No safety issues were observed for both techniques and the EBUS technique produced more cell block material when 22 G needle was compared to transdermal biopsy in peritracheal lesions.Entities:
Keywords: 19g needle; 22g; EBUS; convex; thyroid cancer; transdermal biopsy
Mesh：
Year: 2021 PMID： 33482695 DOI： 10.1080/17434440.2021.1880891
Source DB: PubMed Journal: Expert Rev Med Devices ISSN： 1743-4440 Impact factor: 3.166